Indonesia’s BPOM Reports Prohibited Ingredients In Mojokerto Cosmetics

Indonesia’s food and drug authority, BPOM, has reported prohibited ingredients in cosmetics sampled at an unlicensed production facility in Mojokerto, East Java. Its 19 October announcement follows an inspection on 8 October 2026.

Products And Test Findings

Inspectors found creams, lotions and toners without marketing authorisation in plain, unlabelled packaging. BPOM valued the cosmetics concerned at more than Rp16 billion.

Testing of samples identified retinoic acid, dexamethasone, hydroquinone and mometasone furoate. BPOM describes these as ingredients prohibited in cosmetics. The confirmed sample results are separate from its list of pharmaceutical raw materials found at the premises.

Investigation Continues

BPOM says it secured the goods at the facility and sampled finished and bulk products. The case remains under further investigation to identify those involved and the methods used.

The release says administrative sanctions, including product destruction, may apply. It does not report a final conviction or a completed destruction order.